Down syndrome and megakaryocytic leukemia/transient myeloproliferative disorder: when does it begin?

被引:1
|
作者
Taub, JW [1 ]
机构
[1] Childrens Hosp Michigan, Detroit, MI 48201 USA
关键词
D O I
10.1182/blood-2003-03-0913
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:4228 / 4228
页数:1
相关论文
共 50 条
  • [21] Transient myeloproliferative disorder in children with Down syndrome: clarity to this enigmatic disorder
    Gamis, Alan S.
    Smith, Franklin O.
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 159 (03) : 277 - 287
  • [23] MONITORING OF TRANSIENT MYELOPROLIFERATIVE DISORDER AND LEUKEMIA IN DOWN'S SYNDROME : A SINGLE UNIVERSITY HOSPITAL STUDY
    Park, J. E.
    Hwang, I.
    HAEMATOLOGICA, 2017, 102 : 818 - 818
  • [24] ACUTE MEGAKARYOBLASTIC LEUKEMIA FOLLOWING TRANSIENT MYELOPROLIFERATIVE DISORDER IN A PATIENT WITHOUT DOWN-SYNDROME
    BRISSETTE, MD
    DUVALARNOULD, BJ
    GORDON, BG
    COTELINGAM, JD
    AMERICAN JOURNAL OF HEMATOLOGY, 1994, 47 (04) : 316 - 319
  • [25] Analysis of GATA1 mutations in Down syndrome transient myeloproliferative disorder and myeloid leukemia
    Alford, Kate A.
    Reinhardt, Katarina
    Garnett, Catherine
    Norton, Alice
    Boehmer, Katarina
    von Neuhoff, Christine
    Kolenova, Alexandra
    Marchi, Emanuele
    Klusmann, Jan-Henning
    Roberts, Irene
    Hasle, Henrik
    Reinhardt, Dirk
    Vyas, Paresh
    BLOOD, 2011, 118 (08) : 2222 - 2238
  • [26] TRANSIENT MYELOPROLIFERATIVE DISORDER ASSOCIATED WITH DOWN-SYNDROME AND HYPOTHYROIDISM
    SATAR, M
    TANYELI, A
    ATICI, A
    ANTMEN, B
    BINGOL, G
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1995, 12 (01) : 95 - 96
  • [27] Proinflammatory cytokinemia associated with transient myeloproliferative disorder in Down syndrome
    Shimadaa, A
    Maruyama, K
    Shitara, T
    Kato, M
    Cho, K
    Kobayashi, T
    Fujiu, T
    Tsuchida, Y
    Nishida, A
    Hayashi, Y
    Minakami, H
    Kozawa, K
    Kimura, H
    BIOLOGY OF THE NEONATE, 2004, 85 (03): : 167 - 172
  • [28] Chemotherapy for transient myeloproliferative disorder in a premature infant with Down syndrome
    Oztekin, O.
    Kalay, S.
    Tezel, G.
    Tayfun, F.
    Kupesiz, A.
    Hangul, M.
    Akcakus, M.
    Oygur, N.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2013, 38 (03) : 262 - 264
  • [29] Hepatocyte growth factor in transient myeloproliferative disorder of Down syndrome
    Hirono, Keiichi
    Miura, Masayoshi
    Kanegane, Hirokazu
    Miyamoto, Masatoshi
    Yoshimura, Naoki
    Ichida, Fukiko
    Ito, Etsuro
    Miyawaki, Toshio
    PEDIATRICS INTERNATIONAL, 2009, 51 (05) : 754 - 755
  • [30] Down syndrome, transient myeloproliferative disorder, and infantile liver fibrosis
    Schwab, M
    Niemeyer, C
    Schwarzer, U
    MEDICAL AND PEDIATRIC ONCOLOGY, 1998, 31 (03): : 159 - 165